Investment
Co-led (with Alpha Wave) Moonwalk Biosciences' oversubscribed $70M Series B to advance adipose-targeted RNAi therapies for obesity and cardiometabolic disease.
Moonwalk Biosciences
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Moonwalk Biosciences
Tempo Therapeutics
Think Bioscience
New ~$100M fund (SEC Form D filing)